Literature DB >> 7002373

Hyperinsulinaemia in hyperprolactinaemic women.

D G Johnston, K G Alberti, M Nattrass, J M Burrin, G Blesa-Malpica, K Hall, R Hall.   

Abstract

The metabolic sequelae of hyperprolactinaemia were studied over a 12 h period of normal meals and activity in nine young females hyperprolactinaemic subjects and fourteen matched controls. In the patients, fasting blood glucose and serum insulin concentrations were normal, as was the blood glucose response to meals; the insulin rise with meals was, however, exaggerated and hyperinsulinaemia persisted throughout the day (mean +/- SEM 12 h serum insulin, 26 +/- 8 vs. 16 +/- 9 mu/l, P < 0.01). Blood lactate, pyruvate and alanine response to meals was also increased. Blood glycerol (mean 12 h blood glycerol 0.06 +/- 0.01 vs. 0.09 +/- 0.01 mmol/l, P < 0.01) and blood 3-hydroxybutyrate (mean 12 h blood 3-hydroxybutyrate 0.03 +/- 0.01 vs. 0.05 +/- 0.01 mmol/l, P < 0.05) concentrations were lower in hyperprolactinaemic subjects. There was a strong negative correlation between mean insulin and mean 3-hydroxybutyrate levels in the afternoon period (rs = -0.92, P < 0.01). Excess circulating prolactin in young female is associated with normoglycaemic hyperinsulinaemia. The changes in blood metabolite levels observed are probably secondary to the increased insulin concentrations.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7002373     DOI: 10.1111/j.1365-2265.1980.tb03397.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  13 in total

1.  Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy.

Authors:  Katarina Berinder; Thomas Nyström; Charlotte Höybye; Kerstin Hall; Anna-Lena Hulting
Journal:  Pituitary       Date:  2011-09       Impact factor: 4.107

2.  Insulin sensitivity and hyperprolactinemia.

Authors:  A Tuzcu; M Bahceci; M Dursun; C Turgut; S Bahceci
Journal:  J Endocrinol Invest       Date:  2003-04       Impact factor: 4.256

3.  Timed bromocriptine administration reduces body fat stores in obese subjects and hyperglycemia in type II diabetics.

Authors:  A H Meier; A H Cincotta; W C Lovell
Journal:  Experientia       Date:  1992-03-15

4.  Chronic hyperprolactinemia and plasma lipids in women.

Authors:  H M Heshmati; G Turpin; J L de Gennes
Journal:  Klin Wochenschr       Date:  1987-06-01

5.  BMI, apolipoprotein B/apolipoprotein A-I ratio, and insulin resistance in patients with prolactinomas: a pilot study in a Chinese cohort.

Authors:  Xiao-Bing Jiang; Dong-Sheng He; Zhi-Gang Mao; Xiang Fan; Ni Lei; Bin Hu; Bing-Bing Song; Yong-Hong Zhu; Hai-Jun Wang
Journal:  Tumour Biol       Date:  2013-01-24

6.  Hyperprolactinaemia in male diabetics.

Authors:  A D Mooradian; J E Morley; C J Billington; M F Slag; M K Elson; R B Shafer
Journal:  Postgrad Med J       Date:  1985-01       Impact factor: 2.401

7.  Increased carotid intima media thickness is associated with prolactin levels in subjects with untreated prolactinoma: a pilot study.

Authors:  Xiao-Bing Jiang; Cui-Ling Li; Dong-Sheng He; Zhi-Gang Mao; Dong-Hong Liu; Xiang Fan; Bin Hu; Yong-Hong Zhu; Hai-Jun Wang
Journal:  Pituitary       Date:  2014-06       Impact factor: 4.107

8.  Severe hyperprolactinaemia is associated with decreased insulin binding in vitro and insulin resistance in vivo.

Authors:  G Schernthaner; R Prager; C Punzengruber; A Luger
Journal:  Diabetologia       Date:  1985-03       Impact factor: 10.122

9.  Bromocriptine treatment over 12 years in acromegaly: effect on glucose tolerance and insulin secretion.

Authors:  H Rau; P H Althoff; K Schmidt; K Badenhoop; K H Usadel
Journal:  Clin Investig       Date:  1993-05

10.  The short-term effects of risperidone-induced hyperprolactinemia on lipid metabolism in drug-naïve children and adolescents.

Authors:  Eun Jin Park; Young-Min Park
Journal:  Psychiatry Investig       Date:  2015-01-12       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.